Dynavax Technologies Corporation Message Board
-
Give me 1 good reason to own this stock
Because i have been looking and I must be missing something because i don't see one. Just because a stock falls doesn't mean it is a good buy there is a reason for the decline. INSIDER SELLING and cash burn and over priced. Man just look at the R and D cost.
-
with the recent setback in the FDA and the drop in the stock's price, the company may become an even more inviting target for a takeover. Recall a similar situation with Medarex some years ago, when that company's trial for ipilimumab ('ipi') for the treatment of metastatic melanoma yielded marginally positive results. The stock was languishing around $6-8 a share when Bristol-Myers Squibb (BMY) surprised the Street and bought the company for $16 per share. The drug is today marketed as Yervoy. Surprises do happen!
- 1 Reply to milon5167
-
Thanks for the reply. I was just looking at the fin. because it was being pumped in a few rooms.
-
you realize you're looking at a biotech with no approved drugs right. Why would you own it? Because you think its going to get bought or get a drug approved. No other reason
-
To watch short POS like you lose your #$%$ on this stock
- 2 Replies to t.east44
-
One way or the other, DVAX at current price is a superb buy. FDA will approve its vaccine's restrictive use for population from 40 to 70, as the co originally applied for. S/P will go up upon the news. In time it will be approved for those under 40, if it is not taken over by a big pharma. Such setbacks provide the opportunities to add to position for the ultimate gain within a year at most.
-
I don't short stocks I have a cash account.
-